Faron Pharmaceuticals Oy (DI) (FARN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

142.50p
   
  • Change Today:
    -5.00p
  • 52 Week High: 350.00
  • 52 Week Low: 92.50
  • Currency: UK Pounds
  • Shares Issued: 104.62m
  • Volume: 6,706
  • Market Cap: £149.09m
  • Beta: 1.67

Latest Trades

Time Price Volume Value Buy/Sell Type
21-Nov-2024 16:04 143.50p 1,000 £1,435 Buy O
21-Nov-2024 15:48 140.00p 130 £182 Sell O
21-Nov-2024 15:39 143.50p 340 £488 Buy O
21-Nov-2024 15:38 143.50p 688 £987 Buy O
21-Nov-2024 15:26 144.50p 1,550 £2,240 Buy O
21-Nov-2024 15:19 141.00p 1,248 £1,760 Sell O
21-Nov-2024 14:38 145.00p 750 £1,088 Sell O
21-Nov-2024 09:04 148.00p 1,000 £1,480 Buy O

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

FARN Market Data

Currency UK Pounds
Share Price 142.50p
Change Today -5.00p
% Change -3.39 %
52 Week High 350.00
52 Week Low 92.50
Volume 6,706
Shares Issued 104.62m
Market Cap £149.09m
Beta 1.67

FARN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
Market averageMarket averageMarket averageMarket averageMarket average
52% below the sector average52% below the sector average52% below the sector average52% below the sector average52% below the sector average
Price Trend
Market averageMarket averageMarket averageMarket averageMarket average
51.02% below the sector average51.02% below the sector average51.02% below the sector average51.02% below the sector average51.02% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 1
Total 3
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

FARN Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:04 1,000 @ 143.50p
15:48 130 @ 140.00p
15:39 340 @ 143.50p
15:38 688 @ 143.50p
15:26 1,550 @ 144.50p

FARN Key Personnel

CFO Yrjö E K Wichmann
CEO Juho Jalkanen
Chair Tuomo Pätsi

Top of Page